COMMUNIQUÉS West-GlobeNewswire

Shire plc : Rule 2.9 Announcement
03/08/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 3 August 2018 [...]
Fagron realised organic turnover growth of 8.5%
03/08/2018
Regulated information | Consolidated results for the first semester of 2018 Nazareth (Belgium)/Rotterdam (the Netherlands), 3 August 2018 Fagron realised organic turnover growth of 8.5% Organic turnover growth in all [...]
HitGen Launching Initiative to Discover New Medicines to Combat Tuberculosis and Malaria
03/08/2018
Grant Funding provided by the Bill & Melinda Gates Foundation to Use HitGen’s DNA-Encoded Library Technology CHENGDU, China, Aug. 03, 2018 (GLOBE NEWSWIRE) -- HitGen Ltd., a privately held biotech company, announced [...]
Idera Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Corporate Update
02/08/2018
Abstract accepted for 2018 European Society of Medical Oncology Annual Meeting Cash runway into first quarter of 2020 EXTON, Pa., Aug. 02, 2018 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (NASDAQ: IDRA), a [...]
Profound Medical to Release Second Quarter 2018 Financial Results on August 14 – Conference Call to Follow
02/08/2018
TORONTO, Aug. 02, 2018 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX:PRN; OTCQX:PRFMF) (“Profound” or the “Company”), the only company to provide a therapeutics platform that provides the precision of real-time [...]
Emergent BioSolutions Reports Financial Results for Second Quarter and Six Months of 2018
02/08/2018
Q2 2018 total revenues of $220 million, net income of $50 million Reaffirms full year 2018 financial forecast and operational goals GAITHERSBURG, Md., Aug. 02, 2018 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: [...]
The Ensign Group Reports Second Quarter Results
02/08/2018
Conference Call and Webcast scheduled for tomorrow, August 3, 2018 at 10:00 am PT MISSION VIEJO, Calif., Aug. 02, 2018 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq:ENSG), the parent company of the Ensign™ group of [...]
Alpha Pro Tech, Ltd. Announces Financial Results for the Second Quarter Ended June 30, 2018
02/08/2018
Revenue for the second quarter of 2018 increased 7.3% to $12.1 million, compared to $11.3 million for the second quarter of 2017 Net income for the second quarter of 2018 was $959,000, or $0.07 per diluted share, [...]
Corvus Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Business Update
02/08/2018
BURLINGAME, Calif., Aug. 02, 2018 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company focused on the development and commercialization of precisely targeted [...]
Tetraphase Pharmaceuticals Reports Second Quarter 2018 Financial Results and Recent Highlights
02/08/2018
WATERTOWN, Mass., Aug. 02, 2018 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a biopharmaceutical company focused on developing and commercializing novel antibiotics to treat life-threatening [...]
Alphatec Reports Second Quarter 2018 Financial Results
02/08/2018
CARLSBAD, Calif., Aug. 02, 2018 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“ATEC” or the “Company”) (Nasdaq: ATEC), a provider of innovative spine surgery solutions with a mission to improve patient lives through the [...]
IRIDEX Announces 2018 Second Quarter Results and Raises Full Year 2018 Guidance
02/08/2018
MOUNTAIN VIEW, Calif., Aug. 02, 2018 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today reported financial results for the second quarter and six months ended June 30, 2018. Second Quarter Highlights Cyclo G6™ [...]
Keryx Biopharmaceuticals to Host Conference Call of Second Quarter 2018 Financial Results on Wednesday, August 8, 2018
02/08/2018
BOSTON, Aug. 02, 2018 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX), a biopharmaceutical company focused on bringing innovative medicines to people with kidney disease, today announced that it will [...]
Marrone Bio Innovations Appoints Large Growers, Keith McGovern and Stuart Woolf, to Board of Directors
02/08/2018
Company Forms Advisory Council to Advise the Board and Management’s Strategic Vision for the Company DAVIS, Calif., Aug. 02, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (MBI) (NASDAQ: MBII), a leading [...]
TESARO Announces Second-Quarter 2018 Operating Results
02/08/2018
ZEJULA ® Q2 net sales totaled $54 million compared to $26 million for Q2 2017 QUADRA sNDA submission planned for Q4 2018 PRIMA Phase 3 ZEJULA monotherapy trial in first-line ovarian cancer regardless of biomarker status [...]
Fluidigm Announces Second Quarter 2018 Financial Results
02/08/2018
Total revenue increases 11 percent to $26.4 million Mass cytometry revenue growth of 32 percent Total consumables revenue growth of 19 percent SOUTH SAN FRANCISCO, Calif., Aug. 02, 2018 (GLOBE NEWSWIRE) -- Fluidigm [...]
Corcept Therapeutics to Announce Second Quarter Financial Results, Provide Corporate Update and Host Conference Call
02/08/2018
MENLO PARK, Calif., Aug. 02, 2018 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced it will report second quarter financial results and provide a corporate update on August 9, 2018. [...]
Ultragenyx Reports Second Quarter 2018 Financial Results and Corporate Update
02/08/2018
NOVATO, Calif, Aug. 02, 2018 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today reported [...]
Aeterna Zentaris to Announce Second Quarter 2018 Financial and Operating Results on August 9, 2018
02/08/2018
CHARLESTON, S.C., Aug. 02, 2018 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ:AEZS) (TSX: AEZS) will announce its second quarter 2018 financial and operating results after market close on Thursday, August 9, 2018. [...]

Pages